Plasma IGF-1 levels are instead low in humans with SCD [33] and in sickle mice that express human hemoglobin S and phenocopy many of the complications of SCD [34,35], suggesting that IGF-1-mediated neuroprotection may be impaired in SCD. The gene discussed is IGF1; the disease is Schnyder corneal dystrophy.